Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegl, E; Schimetta, W; Gisslinger, B; Ruckser, R; Gastl, G; Gisslinger, H.
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.
Eur J Haematol. 2016; 97(6):511-516
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Sormann Siegfried

Dimensions Citations:

Plum Analytics:
Although guidelines recommend normalization of platelet counts as an appropriate endpoint for treatment in high-risk essential thrombocythemia (ET), retrospective studies could not prove a correlation of diagnostic platelet counts with an increased thrombotic rate. There is, however, an increasing evidence that leukocytosis is an important risk factor for arterial thrombosis in myeloproliferative neoplasms. This study considers the Austrian cohort of a European registry regarding the platelet-lowering therapeutic anagrelide. Influence of platelet and white blood cell (WBC) counts on thrombotic risk was assessed. Using the calculated cutoffs of 574.5 G/L for platelets and 8.48 G/L for WBC counts, respectively, the Cox regression analysis revealed a clear influence of elevated platelets (P = 0.008) and WBC counts (P = 0.011) on the occurrence of major thrombotic events. The time to a major thrombotic event was shortest (P < 0.001) and the frequency related to 100 patient-years was highest (P = <0.001) when both platelet and WBC counts ranged above the calculated cutoffs. Our data add evidence to the impact of platelet and WBC counts on thrombosis in ET. We suspect a particular interaction between platelets and WBC which might be based on a biological interplay depending on particular cell counts. © 2016 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Blood Platelets -
Female -
Follow-Up Studies -
Humans -
Kaplan-Meier Estimate -
Leukocyte Count -
Male -
Middle Aged -
Platelet Aggregation Inhibitors - therapeutic use
Prognosis -
Proportional Hazards Models -
Quinazolines - therapeutic use
Registries -
Risk Assessment -
Thrombocythemia, Essential - blood
Thrombocythemia, Essential - complications
Thrombocythemia, Essential - diagnosis
Thrombocythemia, Essential - epidemiology
Thrombosis - blood
Thrombosis - drug therapy
Thrombosis - epidemiology
Thrombosis - etiology

Find related publications in this database (Keywords)
platelet count
white blood cell count
thrombosis risk
essential thrombocythemia
© Meduni Graz Impressum